NCT07640074

Brief Summary

A triple-blind, parallel group, randomized trial with an allocation ratio of 1:1. Participants randomly allocated into two groups A and B. In group A, nano-reinforced glass ionomer restoration will be utilized while in group B, glass ionomer restoration without nanoparticles was used. Parameters of clinical performance measured will be: A. Surface structure B. Anatomical shape C. marginal adhesion. Clinical performance of Restorations will be assessed with4-level Ryge's scale at baseline, after 1, 3 and 6 months. The numerical Ryge's scale will be used for comparison of quality of restoration in subsequent control clinical examinations and tracking its changes over time. Parameters will be evaluated on standardized scale 0-3. Restorations that will be rated 0 (very good - ideal condition) and 1 (satisfying - requiring minor corrections) will be considered clinically acceptable. Restorations with rating 2 (need for deferred replacement of the restoration) or 3 (unacceptable - restoration needs to be replaced immediately) will be considered clinically unacceptable.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
4mo left

Started Jun 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress34%
Jun 2026Dec 2026

First Submitted

Initial submission to the registry

May 26, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 10, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

June 10, 2026

Status Verified

May 1, 2026

Enrollment Period

2 months

First QC Date

May 26, 2026

Last Update Submit

June 5, 2026

Conditions

Keywords

Glass ionomer cementTitania nanoparticlesPrimary teeth

Outcome Measures

Primary Outcomes (1)

  • Measure clinical behavior of restorations with the use of a 4-level Ryge's scale having 0-3 standardized scale. Parameters measured will be; 1. Surface structure 2-. Anatomical shape 3. marginal adhesion

    Restorations will be assessed with4-level Ryge's scale at baseline, after 1, 3 and 6 months. The numerical Ryge's scale allows for comparison of quality of restoration in subsequent control clinical examinations and tracking its changes over time. Parameters will be evaluated on standardized scale 0-3. Restorations that were rated 0 (very good - ideal condition) and 1 (satisfying - requiring minor corrections) will be considered clinically acceptable. Restorations with rating 2 (need for deferred replacement of the restoration) or 3 (unacceptable - restoration needs to be replaced immediately) were considered clinically unacceptable.Parameters measured will be: A. Surface structure ( colour, smoothness, gloss, discolouration) B. Anatomical shape (restoration of anatomical shape, nodules and shear surface) C. marginal adhesion (presence of a marginal fissure, discolouration, cracks, damage to the edges of the filling, secondary caries)

    6 months

Study Arms (2)

Group A (Nano-reinforced glass ionomer)

EXPERIMENTAL

glass ionomer restoration reinforced with coconut derived- titania nanoparticles

Drug: Nano-reinforced glass ionomer

Experimental: Group B (Conventional glass ionomer)

EXPERIMENTAL

glass ionomer restoration without nanoparticles

Drug: glass ionomer without nanoparicles

Interventions

Group A (glass ionomer restoration reinforced with coconut derived- titania nanoparticles)

Group A (Nano-reinforced glass ionomer)

Group B ( glass ionomer restoration without nanoparticles)

Experimental: Group B (Conventional glass ionomer)

Eligibility Criteria

Age5 Years - 9 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shaheed Zulfiqar Ali Bhutto Medical University

Islamabad, Pakistan

Location

Related Publications (1)

  • Padilla-Ocampo CA, Medecigo-Costeira D, Pioquinto-Mendoza JR, Navarrete-Hernandez JJ, Mendoza-Rodriguez M, Marquez-Corona ML, Villalobos-Rodelo JJ, Casanova-Rosado JF, Medina-Solis CE, Maupome G. Short-Term Assessment of Cention N vs. Glass Ionomer Cement (Fuji IX) as a Definitive Restoration in the Primary Dentition of Mexican Children: A Pilot Study. Cureus. 2025 May 9;17(5):e83784. doi: 10.7759/cureus.83784. eCollection 2025 May.

    PMID: 40491641BACKGROUND

MeSH Terms

Conditions

Dental Caries

Interventions

glass ionomer

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Triple (Participant, Care Provider, Outcomes Assessor) In this triple-blind trial, participants, care provider and outcome assessor were unaware of the study groups.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 26, 2026

First Posted

June 10, 2026

Study Start

June 1, 2026

Primary Completion

August 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

June 10, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations